Yangzijiang Shipbuilding shares slide 5% as Maersk warning jolts shipping-linked stocks

Yangzijiang Shipbuilding shares slide 5% as Maersk warning jolts shipping-linked stocks

Singapore, Feb 6, 2026, 14:58 SGT — Regular session

  • Shares of Yangzijiang Shipbuilding slipped roughly 5%, trading at S$3.20 in the afternoon session
  • Shares sank after Maersk flagged that ongoing freight-rate pressures might weigh on earnings through 2026
  • Attention shifts to shipping-rate trends and Yangzijiang’s upcoming earnings release in early March

Shares of Yangzijiang Shipbuilding (Holdings) Ltd dropped roughly 5% on Friday afternoon, weighing on Singapore’s industrial sector as investors pulled back from shipping-related stocks. By 2:49 p.m., the stock was at S$3.20, down 17 Singapore cents from Thursday’s close. (SG Investors)

The drop followed A.P. Moller-Maersk’s warning that increased ship capacity and a shift back to shorter Red Sea routes could drive freight rates lower, denting profits in 2026. “New ships are coming in,” Maersk CEO Vincent Clerc noted, adding that Red Sea shipping is “likely to reopen.” Meanwhile, Jyske Bank analyst Haider Anjum flagged that longer vessel lifespans “point in the other direction” for freight rates. (Reuters)

Yangzijiang took the biggest hit on the Singapore Exchange early Friday, sliding 5.3% by 9:30 a.m., shedding over S$700 million in market value, according to The Business Times. The sharp drop reflected jitters over Maersk’s earnings outlook and its announced job cuts. (The Business Times)

Shares of Yangzijiang traded between S$3.16 and S$3.30 today, following a close of S$3.37 on Thursday, according to price data. The stock has moved within a 52-week range of S$1.80 to S$3.75. (Investing)

The sell-off unfolded alongside a wider risk-off mood in the region. Singapore shares dropped 0.7%, while Asian stocks retreated as investors stepped away from tech and other risky assets, Reuters noted. eToro analyst Zavier Wong called it a move by “investors de-risking and locking in gains.” (Reuters)

Maersk, a key indicator for global trade, forecasted container market growth of 2% to 4% in 2026 and signaled a stricter approach on costs amid softening freight rates. The Danish company also announced plans to slash around 1,000 corporate jobs and reduce annual corporate overhead by $180 million. (Maersk)

For shipbuilders, the connection isn’t direct but remains impossible to overlook. Liner earnings and freight rates shape demand for new vessels, despite contracts being inked years in advance and deliveries stretched over lengthy lead times.

Maersk’s outlook is based on a slow reopening of the Red Sea route, which would release vessel capacity currently caught on extended detours around Africa, The Business Times reported. This tends to put downward pressure on freight rates— a key metric shipowners use to gauge how bold to be with new orders.

The read-through isn’t straightforward. Should disruptions continue or demand hold up stronger than predicted, rate pressure might ease, helping the sector stabilize fast. On the flip side, if rates drop quickly, sentiment could shift to caution, sparking more volatility in shipbuilding stocks.

Investors are eyeing Yangzijiang’s upcoming earnings on March 4, eager for updates on order flow and customer demand, especially after Maersk’s recent caution on the shipping sector. (TipRanks)

Stock Market Today

  • AELIS.PA Dips 6.16% Pre-Market on EURONEXT Amid Clinical Trial and Valuation Concerns
    February 6, 2026, 2:31 AM EST. AELIS.PA shares fell 6.16% to €1.37 in early trading on EURONEXT with volume nearly double the average, reflecting heightened investor activity. The Bordeaux biotech faces pressure from upcoming clinical trial readouts and cash runway concerns. Despite trading above its 50- and 200-day moving averages, AELIS.PA reports negative earnings per share of -€0.64 and a price-to-sales ratio of 8.01, signaling stretched valuation for a small-cap biotech. Its debt-to-equity ratio stands at 1.13, pointing to rising leverage. The Meyka AI model assigns a HOLD rating with a fair value estimate of €3.06. Investors should consider risks tied to trial delays, binary outcomes, and sector volatility within healthcare, where peers command substantially higher price-to-earnings ratios.
Evolution Mining (EVN) share price slides again as metals whipsaw; eyes turn to Feb 11 results
Previous Story

Evolution Mining (EVN) share price slides again as metals whipsaw; eyes turn to Feb 11 results

Singtel share price slips again: what’s moving Singapore Telecommunications stock after the STT GDC deal
Next Story

Singtel share price slips again: what’s moving Singapore Telecommunications stock after the STT GDC deal

Go toTop